Intercept Pharmaceuticals, Inc.
Farnesoid X receptor modulators

Abstract:

The present application provides a compound of formula I: ##STR00001## or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R.sup.1-R.sup.10, m, n, p, and are as described herein. The present invention relates generally to FXR modulators and to methods of making and using said compounds.